Swiss government supports legalising medical cannabis
The government has recommended the approval of the sale of cannabis for medical purposes. It also wants to legalise pilot tests to establish how a general legalisation would impact consumers.
This content was published on
1 minute
SDA-ATS/ln
The changes are intended to facilitate access to medical cannabis for patients in Switzerland, the Federal Office of Publish Health (FOPH) wrote in a press release.
In 2017, around 3000 patients were treated with medical cannabis, often people with incurable diseases or terminal cancer. But currently permission is only granted on a case by case basis, and hinders access, delaying treatment.
The home affairs ministry has now been tasked with proposing a change to the law by summer 2019.
Recreational use
In its announcement on Wednesday, the government also said it wanted to allow pilot studies to go ahead to examine the drug’s effects when used recreationally.
Although cannabis for recreational purposes is illegal, the government said the number of users had remained stable and the black market was flourishing.
That’s why the authorities in several Swiss cities and cantons have expressed interest in the studies. So far, such investigations have been banned.
Interested parties have until October 25 to provide input on the pilot studies’ proposal before it goes to parliament for debate.
More
More
How cannabis becomes medicine
This content was published on
Chemist Markus Lüdi is Switzerland’s only producer of a natural tincture made from cannabis. In his laboratory in Burgdorf in canton Bern he demonstrates how a liquid drug can be produced from cannabis flowers. (Photos: Thomas Kern, swissinfo.ch)
University students in Switzerland join Gaza protest wave
This content was published on
Pro-Palestinian activists occupied university buildings in Lausanne, Geneva and Zurich on Tuesday, widening the protest movement in the Alpine nation.
TradeXBank to resume full operations after Sberbank Switzerland taken off sanctions list
This content was published on
TradeXBank, the former Swiss branch of Russia’s Sberbank, will be able to resume its dollar-denominated activities from the second half of this year.
Geneva decides not to remove controversial memorials
This content was published on
The city of Geneva has presented an action plan regarding a series of controversial local statues and monuments of historical figures linked to racism, colonialism or slavery.
University of Lausanne calls for end to pro-Palestine sit-in
This content was published on
The pro-Palestinian occupation continues at the University of Lausanne (UNIL). On Monday evening, a group of students refused to agree to the deadline set by the rectorate.
Ukraine peace conference should include Russia, says Chinese ambassador
This content was published on
China supports a peace conference on the Ukraine war that would see equal participation of all parties, says Chinese Ambassador to Russia Zhang Hanhui.
This content was published on
A majority of Swiss citizens have open attitudes towards various infertility treatments, including even egg donation, which is currently prohibited.
Reports of Swiss cyber fraud almost doubled in six months
This content was published on
The head of the new Federal Office for Cybersecurity (FOC), Florian Schütz, has presented a new strategy after just over four months in office.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
‘Swiss marijuana champion’ finds new markets with ‘cannabis light’
This content was published on
There’s decaffeinated coffee, alcohol-free beer, and now marijuana that doesn’t make you high. A producer reveals the hidden side of the market.
This content was published on
Hemp containing active ingredient cannabidiol (CBD) can now be bought in Swiss branches of German discount supermarket chain Lidl.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.